A juvenile case with nonalcoholic steatohepatitis and traditional Korean medicine-based treatment

다국어 초록 (Multilingual Abstract)

Nonalcoholic fatty liver disease (NAFLD) has become the common cause leading to chronic liver diseases recently. Unlikely past humankind history, NAFLD is like a new illness especially in developed countries due to decreased number of hepatic virus carriers and increased population with obesity. Among subjects with NAFLD, development of nonalcoholic steatohepatitis (NASH) is a key pathological step which determines the clinical progression. This study reports a case of a boy who has suffered from NASH for 2 years. This study aims to discuss the clinical feature, risk aspect, and treatment strategy of NASH as well as potential of traditional Korean medicine (TKM) therapies.

참고문헌 (Reference)

1 Golabi P, "Treatment strategies fornonalcoholic fatty liver disease and nonalcoholicsteatohepatitis" 21 : 739-753, 2017

2 Romero-Gómez M, "Treatment of NAFLD with diet, physical activity and exercise" 67 : 829-846, 2017

3 Kovalic AJ, "The role of nonalcoholic fatty liverdisease on cardiovascular manifestations and outcomes" 22 : 141-174, 2018

4 Anderson EL, "The prevalence of non-alcoholic fatty liver diseasein children and adolescents: a systematic review andmeta-analysis" 10 : e0140908-, 2015

5 Yu J, "The pathogenesis ofnonalcoholic fatty liver disease: interplay between diet, gutmicrobiota, and genetic background" 2016 : 2862173-, 2016

6 Adams LA, "The natural history of nonalcoholic fattyliver disease : a population based cohort study" 129 : 113-121, 2005

7 Airaghi L, "Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis" 268 : 27-31, 2017

8 Arguello G, "Recent insightson the role of cholesterol in non-alcoholic fatty liver disease" 1852 : 1765-1778, 2015

9 Anstee QM, "Progression of NAFLD todiabetes mellitus, cardiovascular disease or cirrhosis" 10 : 330-344, 2013

10 Zhu JZ, "Prevalence of fatty liver disease and the economy in China:a systematic review" 21 : 5695-5706, 2015

11 Konerman MA, "Pharmacotherapy forNASH: current and emerging" 2017

12 Torres DM, "Nonalcoholic steatohepatitis andnoncirrhotic hepatocellular carcinoma : fertile soil" 32 : 30-38, 2012

13 Adams LA, "Non-alcoholic fattyliver disease and its relationship with cardiovascular diseaseand other extrahepatic diseases" 66 : 1138-1153, 2017

14 Pappachan JM, "Non-alcoholic fatty liver disease : a clinical update" 5 : 384-393, 2017

15 Fan JG, "New trends on obesity andNAFLD in Asia" 67 : 862-873, 2017

16 Finucane MM, "National, regional, and global trends inbody-mass index since 1980: systematic analysis of healthexamination surveys and epidemiological studies with 960country-years and 9$1 million participants" 377 : 557-567, 2011

17 Son CG, "Medicinal herbs and their active compounds for fatty liverdiseases" 2017

18 Puoti C, "Liver steatosis:the new epidemic of the third millennium. Benign liver stateor silent killer?" 46 : 1-5, 2017

19 Marra F, "Lipotoxicity and the gut–liveraxis in NASH pathogenesis" 2017

20 Yao H, "Herbalmedicines and nonalcoholic fatty liver disease" 22 : 6890-6905, 2016

21 Younossi ZM, "Global epidemiology of nonalcoholic fatty liverdisease-meta-analytic assessment of prevalence, incidence,and outcomes" 64 : 73-84, 2016

22 Wree A, "From NAFLD to NASH to cirrhosis – new insights intodisease mechanisms" 10 : 627-636, 2013

23 Younossi ZM, "Clinical andeconomic burden of nonalcoholic fatty liver disease andnonalcoholic steatohepatitis" 22 : 1-10, 2018

24 Park HJ, "Chunggan extract (CGX), methionine-and choline-deficient(MCD) diet-induced hepatosteatosis and oxidative stress inC57BL/6 mice" 32 : 1258-1269, 2013

25 Kim HG, "Chunggan extract (CGX), a traditional Korean herbalmedicine, exerts hepatoprotective effects in a rat model ofchronic alcohol consumption" 27 : 1854-1862, 2013

26 VanWagner LB, "Body mass index trajectories in young adulthoodpredict non-alcoholic fatty liver disease in middle age: the CARDIA cohort study" 2017

27 Lee HY, "Asystematic review on sasang constitutional type-associatedsusceptibility to disorders in Korea" 22 : 950-956, 2016

28 Kim GA, "Association between non-alcoholic fatty liver disease andcancer incidence rate" 2017